Log In
BCIQ
Print this Print this
 

FFP104 (formerly PG102)

  Manage Alerts
Collapse Summary General Information
Company PanGenetics B.V.
DescriptionDeimmunized mAb against CD40
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today